Decoding m 6 Am by simultaneous transcription-start mapping and methylation quantification

ABSTRACT N6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene levels annotations cannot capture the diversity of m6Am modification in the transcriptome. Here we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription. Competing Interest Statement S.R.J. is the co-founder and/or has equity in Chimerna Therapeutics, 858 Therapeutics, and Lucerna Technologies. Footnotes Manuscript file not changed. Update supplmentary file. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE233655 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188510